Page URL:

Stem cell secretions may protect against glaucoma

6 February 2017
Appeared in BioNews 887

Stem cell secretions, called exosomes, appear to protect retinal cells in rats, offering a potential therapy for degenerative eye diseases like glaucoma. 

Researchers say that exosome treatment could avoid the potential risks of using whole stem cells, such as the rejection by the immune system or the development of tumours.

Researchers at the US National Eye Institute (NEI) investigated the effect of exosomes on retinal ganglion cells using rats that had their optic nerve damaged to mimic glaucoma. They injected the rats on a weekly basis with exosomes from bone marrow mesenchymal stem cells, using fluorescent labels to monitor their delivery into the retinal cells.  

The researchers found that exosome-treated rats lost a third of their retinal ganglion cells, compared with a 90 percent loss among untreated rats after optic injury. When the researchers measured the retinal ganglion cells' electrical function, they observed that the exosome-treated cells continued to behave normally. 

Exosomes are membrane-enclosed packages, containing proteins, lipids and micro RNA. Neighbouring cells can take up secreted exosomes, prompting changes in signalling pathways and protein production. 

Exosome therapy avoids the potential risks of using whole stem cells, such as the body rejecting the cells as 'foreign' or uncontrollable cell growth leading to tumours. 'Exosomes can be purified, stored and precisely dosed in ways that stem cells cannot,' explained Dr Ben Mead of the NEI, who led the study, which was published in the journal Stem Cells Translational Medicine

The authors say that it opens the possibility of 'cell-free therapy for traumatic and degenerative ocular disease'. They suggest that the protective effects of exosomes are caused by the transfer of microRNA contained in the exosomes, but more research is needed to understand their contents and how they work. 

'We need to know which particular microRNA – there are more than 2000 different microRNA molecules – are delivered into the retinal ganglion cells and what proteins or signalling pathways are being targeted upon arrival,' said Dr Stanislav Tomarev, a principal investigator at NEI and the study's co-author. 'We also need to attempt to target exosomes to specific sets of neurons and other cell types or groups of cells.'

Glaucoma is caused by a blockage of the drainage tubes in the eye. The resulting increase in pressure damages the optic nerve and can eventually lead to blindness. The associated vision loss is currently incurable, but early treatment can delay disease progression. 

Dr Tomarev added that the exosome approach needs to be optimised and may work best in combination with other therapies. 

Bone Marrow-Derived Mesenchymal Stem Cells-Derived Exosomes Promote Survival of Retinal Ganglion Cells Through miRNA-Dependent Mechanisms
Stem Cells Translational Medicine |  26 January 2017
Stem Cell Exosomes Convey Hope for Cell-Free Glaucoma Treatment
Genetic Engineering and Biotechnology News |  30 January 2017
Stem cell secretions may help treat glaucoma
Medical News Today |  28 January 2017
Stem cell secretions may protect against glaucoma
National Institutes for Health (press release) |  27 January 2017
3 April 2017 - by Emma Laycock 
Men with erectile dysfunction following prostate surgery were able to have intercourse again after receiving an experimental stem cell therapy using cells taken from their own abdomen, a Danish study has shown...
13 February 2017 - by Emma Laycock 
A new blood test can predict how well patients with myelodysplastic syndrome will respond to bone-marrow transplants...
13 January 2017 - by Ayala Ochert 
Scientists have partially reversed blindness in mice using lab-grown retinas made from skin cells...
9 January 2017 - by Paul Waldron 
Researchers in the US and China have developed a 'synthetic stem cell' that can repair tissue damaged by a heart attack...
17 October 2016 - by Dr Jane Currie 
Researchers in Japan have used stem cells from a matched donor to repair damaged heart muscle in macaque monkeys...
21 March 2011 - by Dr Lux Fatimathas 
UK scientists have shown stem cells can be used to successfully stop glaucoma, an eye disorder, in rats. Stem cells were isolated from bone marrow and successfully grafted onto damaged nerves in the eye...
13 August 2007 - by Rose Palmer 
Icelandic and Swedish scientists have discovered two common single letter variations (SNPs) in the sequence of the human genome that appear to account for 99 per cent of cases of exfoliative glaucoma (XFG). The scientists from deCODE genetics and colleagues from the National University Hospital in Rekjavik...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.